Corcept Therapeutics Inc (NAS:CORT)
$ 27.04 0.44 (1.65%) Market Cap: 2.82 Bil Enterprise Value: 2.36 Bil PE Ratio: 25.51 PB Ratio: 5.13 GF Score: 93/100

Q4 2023 Corcept Therapeutics Inc Earnings Call Transcript

Feb 15, 2024 / 10:00PM GMT
Release Date Price: $24.46 (+1.07%)
Operator

Good day and thank you for standing by. Welcome to the Corcept Therapeutics conference call. (Operator Instructions) Please be advised today's conference is being recorded. I would like to turn the call over to Atabak Mokari. Please go ahead.

Atabak Mokari
Corcept Therapeutics Inc - Chief Financial Officer, Treasurer

Hello, everyone. Good afternoon and thank you for joining us. Today, we issued a press release announcing our financial results for the fourth quarter and providing a corporate update, copies available at corcept.com. Our complete financial results will be available when we file our Form 10-K with the SEC. Today's call is being recorded. A replay will be available at the Investors Past Events tab of our website.

Statements during this call, other than statements of historical fact, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties, which may cause actual results to differ materially from those such statements expressed or implied.

These forward-looking statements are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot